Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Kallikrein-1 | ||
Ligand | BDBM50396165 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_862798 (CHEMBL2172818) | ||
Ki | 110±n/a nM | ||
Citation | Caliendo, G; Santagada, V; Perissutti, E; Severino, B; Fiorino, F; Frecentese, F; Juliano, L Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development. J Med Chem55:6669-86 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Kallikrein-1 | |||
Name: | Kallikrein-1 | ||
Synonyms: | KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein | ||
Type: | Enzyme | ||
Mol. Mass.: | 28874.69 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P06870 | ||
Residue: | 262 | ||
Sequence: |
| ||
BDBM50396165 | |||
n/a | |||
Name | BDBM50396165 | ||
Synonyms: | CHEMBL2171750 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H42N8O5 | ||
Mol. Mass. | 546.6623 | ||
SMILES | NC1CCC(C[C@H](NC(=O)Cc2ccccc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CC1 |r,wU:20.20,wD:26.26,6.6,(41.41,-16.5,;41.42,-14.96,;40.09,-14.18,;40.09,-12.65,;41.42,-11.88,;41.42,-10.34,;42.75,-9.57,;42.75,-8.03,;41.41,-7.27,;40.08,-8.04,;41.41,-5.73,;40.08,-4.96,;38.74,-5.73,;37.41,-4.96,;37.41,-3.42,;38.74,-2.65,;40.07,-3.41,;44.08,-10.34,;44.09,-11.88,;45.42,-9.57,;46.75,-10.35,;48.09,-9.59,;49.42,-10.37,;46.74,-11.9,;45.4,-12.66,;48.07,-12.68,;48.06,-14.22,;46.72,-14.98,;46.71,-16.53,;45.37,-17.29,;45.36,-18.84,;44.02,-19.6,;42.68,-18.82,;44.01,-21.14,;49.39,-15,;49.38,-16.55,;50.74,-14.24,;42.76,-12.64,;42.75,-14.19,)| | ||
Structure |